Cargando…
Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665246/ http://dx.doi.org/10.1182/blood-2022-170337 |
| _version_ | 1784831248894525440 |
|---|---|
| author | Ionescu, Filip Ajayi, Eloho Leach, Aamia Alsina, Melissa Bejanyan, Nelli Castaneda-Puglianini, Omar Elmariah, Hany Freeman, Ciara L. Hansen, Doris K. Jain, Michael D. Khimani, Farhad Lazaryan, Aleksandr Liu, Hien D. Locke, Frederick L. McIver, Bryan Mishra, Asmita Nieder, Michael Ochoa, Jose Perez, Lia Pidala, Joseph Baluch, Aliyah Klinkova, Olga Quilitz, Rod Nishihori, Taiga Faramand, Rawan |
| author_facet | Ionescu, Filip Ajayi, Eloho Leach, Aamia Alsina, Melissa Bejanyan, Nelli Castaneda-Puglianini, Omar Elmariah, Hany Freeman, Ciara L. Hansen, Doris K. Jain, Michael D. Khimani, Farhad Lazaryan, Aleksandr Liu, Hien D. Locke, Frederick L. McIver, Bryan Mishra, Asmita Nieder, Michael Ochoa, Jose Perez, Lia Pidala, Joseph Baluch, Aliyah Klinkova, Olga Quilitz, Rod Nishihori, Taiga Faramand, Rawan |
| author_sort | Ionescu, Filip |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9665246 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | The American Society of Hematology. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96652462022-11-16 Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience Ionescu, Filip Ajayi, Eloho Leach, Aamia Alsina, Melissa Bejanyan, Nelli Castaneda-Puglianini, Omar Elmariah, Hany Freeman, Ciara L. Hansen, Doris K. Jain, Michael D. Khimani, Farhad Lazaryan, Aleksandr Liu, Hien D. Locke, Frederick L. McIver, Bryan Mishra, Asmita Nieder, Michael Ochoa, Jose Perez, Lia Pidala, Joseph Baluch, Aliyah Klinkova, Olga Quilitz, Rod Nishihori, Taiga Faramand, Rawan Blood Poster Abstracts The American Society of Hematology. Published by Elsevier Inc. 2022-11-15 2022-11-15 /pmc/articles/PMC9665246/ http://dx.doi.org/10.1182/blood-2022-170337 Text en Copyright © 2022 The American Society of Hematology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Poster Abstracts Ionescu, Filip Ajayi, Eloho Leach, Aamia Alsina, Melissa Bejanyan, Nelli Castaneda-Puglianini, Omar Elmariah, Hany Freeman, Ciara L. Hansen, Doris K. Jain, Michael D. Khimani, Farhad Lazaryan, Aleksandr Liu, Hien D. Locke, Frederick L. McIver, Bryan Mishra, Asmita Nieder, Michael Ochoa, Jose Perez, Lia Pidala, Joseph Baluch, Aliyah Klinkova, Olga Quilitz, Rod Nishihori, Taiga Faramand, Rawan Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience |
| title | Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience |
| title_full | Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience |
| title_fullStr | Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience |
| title_full_unstemmed | Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience |
| title_short | Outpatient Treatment with Anti-Sars-Cov-2 Monoclonal Antibodies and Remdesivir for COVID19 Infections Demonstrates Encouraging Outcomes in Hematopoietic Stem Cell Transplant Recipients: A Single-Center Experience |
| title_sort | outpatient treatment with anti-sars-cov-2 monoclonal antibodies and remdesivir for covid19 infections demonstrates encouraging outcomes in hematopoietic stem cell transplant recipients: a single-center experience |
| topic | Poster Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9665246/ http://dx.doi.org/10.1182/blood-2022-170337 |
| work_keys_str_mv | AT ionescufilip outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT ajayieloho outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT leachaamia outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT alsinamelissa outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT bejanyannelli outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT castanedapuglianiniomar outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT elmariahhany outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT freemanciaral outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT hansendorisk outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT jainmichaeld outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT khimanifarhad outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT lazaryanaleksandr outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT liuhiend outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT lockefrederickl outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT mciverbryan outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT mishraasmita outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT niedermichael outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT ochoajose outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT perezlia outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT pidalajoseph outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT baluchaliyah outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT klinkovaolga outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT quilitzrod outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT nishihoritaiga outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience AT faramandrawan outpatienttreatmentwithantisarscov2monoclonalantibodiesandremdesivirforcovid19infectionsdemonstratesencouragingoutcomesinhematopoieticstemcelltransplantrecipientsasinglecenterexperience |